search
Back to results

SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19

Primary Purpose

SARS CoV 2 Infection, COVID-19

Status
Recruiting
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
Bemnifosbuvir (BEM)
Placebo
Sponsored by
Atea Pharmaceuticals, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for SARS CoV 2 Infection

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Positive SARS-CoV-2 test conducted ≤ 5 days prior to randomization Mild or moderate COVID-19 with symptom onset ≤ 5 days before randomization and at least one COVID-19 related symptom present at time of screening Subject must be high risk, defined below: Age ≥70 years OR Age ≥55 years with one of the following: i) obesity (body mass index [BMI] ≥30 kg/m2) ii) diabetes mellitus iii) cardiovascular disease or hypertension iv) chronic lung disease requiring routine therapy OR Age 50 to 54 years with two of the following: i) obesity (BMI ≥30 kg/m2) ii) diabetes mellitus iii) cardiovascular disease or hypertension iv) chronic lung disease requiring routine therapy OR Age ≥18 years with one of the following: i) Down syndrome, sickle cell disease, dementia, Parkinson's disease, or care home residents ii) One of the following immunocompromising conditions or immunosuppressive treatments: receiving chemotherapy for cancer, hematologic malignancy, being within 2 years of a hematopoietic stem cell transplant, receipt of a solid organ transplant and on immunosuppressive therapy, human immunodeficiency virus (HIV) infection untreated or with CD4+ T lymphocyte count <350 cells per cubic millimeter, moderate/severe primary immunodeficiency, taking immunosuppressive medications Use of adequate contraception for females of childbearing potential Exclusion Criteria: Severe or critical COVID-19 illness Admitted to a hospital within 90 days prior to randomization due to COVID-19 Use of other investigational drugs within 30 days prior to planned dosing, or plans to enroll in another clinical trial of an investigational agent while participating in the present study Initiation or planned initiation of remdesivir for treatment of the current SARS-CoV-2 infection Requirement of prohibited medications, including hydroxychloroquine or amiodarone within 3 months prior to screening. Note: Subjects who had already initiated any COVID-19 drug with antiviral effects intended to treat symptomatic SARS-CoV-2 infection (≥ 24 hours prior to randomization) will be excluded. During screening (or within 24 hours prior to or after randomization), locally available COVID-19 drugs with antiviral effects (including but not limited to nirmatrelvir/ritonavir, molnupiravir, favipiravir, monoclonal antibodies) will be permitted. Other known active viral or bacterial infection at the time of screening, such as influenza and respiratory syncytial virus (RSV). Note: This exclusion does not apply to subjects with stable chronic viral infections, such as chronic hepatitis C virus (HCV) or HIV providing other eligibility criteria are met. Receiving dialysis or have known severe renal impairment History of severe hepatic impairment (Child-Pugh Class C) Known allergy or hypersensitivity to components of study drug

Sites / Locations

  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study siteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SIteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SIteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting
  • Atea Study SiteRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Bemnifosbuvir (BEM)

Placebo

Arm Description

Outcomes

Primary Outcome Measures

Proportion of subjects hospitalized for any cause or died due to any cause

Secondary Outcome Measures

Proportion of subjects hospitalized due to COVID-19 or died due to any cause
Proportion of subjects who died due to any cause
Proportion of subjects with COVID-19-related complications
Proportion of subjects with COVID-19-medically attended visits (hospitalization, emergency room (ER) visit, urgent care visit, physician's office visit, or telemedicine visit) or who died due to any cause
Proportion of subjects with COVID-19 symptom relapse
Proportion of subjects with viral load rebound

Full Information

First Posted
November 26, 2022
Last Updated
October 6, 2023
Sponsor
Atea Pharmaceuticals, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT05629962
Brief Title
SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19
Official Title
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 25, 2022 (Actual)
Primary Completion Date
March 2024 (Anticipated)
Study Completion Date
April 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Atea Pharmaceuticals, Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of the study is to evaluate whether bemnifosbuvir (BEM) is effective and safe in adults with COVID-19 who do not need to be in the hospital but who are at high risk for progression to severe disease. Eligible subjects will be randomly assigned (by chance) to receive BEM or matching placebo orally for 5 days. Co-administration of locally available standard of care (SOC) is allowed. The total duration of the study is 60 days.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
SARS CoV 2 Infection, COVID-19

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
2510 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Bemnifosbuvir (BEM)
Arm Type
Experimental
Arm Title
Placebo
Arm Type
Placebo Comparator
Intervention Type
Drug
Intervention Name(s)
Bemnifosbuvir (BEM)
Other Intervention Name(s)
AT-527
Intervention Description
BEM tablets administered orally every 12 hours (twice a day) for a total of 5 days
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
Placebo tablets administered orally every 12 hours (twice a day) for a total of 5 days
Primary Outcome Measure Information:
Title
Proportion of subjects hospitalized for any cause or died due to any cause
Time Frame
Day 1 through Day 29
Secondary Outcome Measure Information:
Title
Proportion of subjects hospitalized due to COVID-19 or died due to any cause
Time Frame
Day 1 through Day 29
Title
Proportion of subjects who died due to any cause
Time Frame
Day 1 through Day 29; Day 1 through Day 60
Title
Proportion of subjects with COVID-19-related complications
Time Frame
Day 1 through Day 29
Title
Proportion of subjects with COVID-19-medically attended visits (hospitalization, emergency room (ER) visit, urgent care visit, physician's office visit, or telemedicine visit) or who died due to any cause
Time Frame
Day 1 through Day 29; Day 1 through Day 60
Title
Proportion of subjects with COVID-19 symptom relapse
Time Frame
Day 1 through Day 29
Title
Proportion of subjects with viral load rebound
Time Frame
Day 1 through Day 29

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Positive SARS-CoV-2 test conducted ≤ 5 days prior to randomization Mild or moderate COVID-19 with symptom onset ≤ 5 days before randomization and at least one COVID-19 related symptom present at time of screening Subject must be high risk, defined below: Age ≥70 years OR Age ≥55 years with one of the following: i) obesity (body mass index [BMI] ≥30 kg/m2) ii) diabetes mellitus iii) cardiovascular disease or hypertension iv) chronic lung disease requiring routine therapy OR Age 50 to 54 years with two of the following: i) obesity (BMI ≥30 kg/m2) ii) diabetes mellitus iii) cardiovascular disease or hypertension iv) chronic lung disease requiring routine therapy OR Age ≥18 years with one of the following: i) Down syndrome, sickle cell disease, dementia, Parkinson's disease, or care home residents ii) One of the following immunocompromising conditions or immunosuppressive treatments: receiving chemotherapy for cancer, hematologic malignancy, being within 2 years of a hematopoietic stem cell transplant, receipt of a solid organ transplant and on immunosuppressive therapy, human immunodeficiency virus (HIV) infection untreated or with CD4+ T lymphocyte count <350 cells per cubic millimeter, moderate/severe primary immunodeficiency, taking immunosuppressive medications Use of adequate contraception for females of childbearing potential Exclusion Criteria: Severe or critical COVID-19 illness Admitted to a hospital within 90 days prior to randomization due to COVID-19 Use of other investigational drugs within 30 days prior to planned dosing, or plans to enroll in another clinical trial of an investigational agent while participating in the present study Initiation or planned initiation of remdesivir for treatment of the current SARS-CoV-2 infection Requirement of prohibited medications, including hydroxychloroquine or amiodarone within 3 months prior to screening. Note: Subjects who had already initiated any COVID-19 drug with antiviral effects intended to treat symptomatic SARS-CoV-2 infection (≥ 24 hours prior to randomization) will be excluded. During screening (or within 24 hours prior to or after randomization), locally available COVID-19 drugs with antiviral effects (including but not limited to nirmatrelvir/ritonavir, molnupiravir, favipiravir, monoclonal antibodies) will be permitted. Other known active viral or bacterial infection at the time of screening, such as influenza and respiratory syncytial virus (RSV). Note: This exclusion does not apply to subjects with stable chronic viral infections, such as chronic hepatitis C virus (HCV) or HIV providing other eligibility criteria are met. Receiving dialysis or have known severe renal impairment History of severe hepatic impairment (Child-Pugh Class C) Known allergy or hypersensitivity to components of study drug
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Clinical Trials Administrator
Phone
1-(857) 284-8891
Email
ateaclinicaltrials@ateapharma.com
Facility Information:
Facility Name
Atea Study Site
City
Long Beach
State/Province
California
ZIP/Postal Code
90806
Country
United States
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Los Angeles
State/Province
California
ZIP/Postal Code
90017
Country
United States
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Coral Gables
State/Province
Florida
ZIP/Postal Code
33134
Country
United States
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Doral
State/Province
Florida
ZIP/Postal Code
33172
Country
United States
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33155
Country
United States
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33185
Country
United States
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
North Miami Beach
State/Province
Florida
ZIP/Postal Code
33179
Country
United States
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Tampa
State/Province
Florida
ZIP/Postal Code
33612
Country
United States
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Tampa
State/Province
Florida
ZIP/Postal Code
33615
Country
United States
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
West Palm Beach
State/Province
Florida
ZIP/Postal Code
33409
Country
United States
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Bronx
State/Province
New York
ZIP/Postal Code
10467
Country
United States
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Providence
State/Province
Rhode Island
ZIP/Postal Code
02903
Country
United States
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Rock Hill
State/Province
South Carolina
ZIP/Postal Code
29732
Country
United States
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
DeSoto
State/Province
Texas
ZIP/Postal Code
75115
Country
United States
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Houston
State/Province
Texas
ZIP/Postal Code
77065
Country
United States
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Splendora
State/Province
Texas
ZIP/Postal Code
77372
Country
United States
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Rosario
State/Province
Santa Fe
ZIP/Postal Code
2000
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
San Miguel De Tucumán
State/Province
Tucuman
ZIP/Postal Code
4000
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Tucumán
State/Province
Tucuman
ZIP/Postal Code
4000
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Salvador
State/Province
Bahia
ZIP/Postal Code
40150
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Fortaleza
State/Province
Ceara
ZIP/Postal Code
60160-070
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Fortaleza
State/Province
Ceara
ZIP/Postal Code
60430-370
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Brasília
State/Province
Distrito Federal
ZIP/Postal Code
70710-100
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Cachoeiro De Itapemirim
State/Province
Espirito Santo
ZIP/Postal Code
2938-020
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Serra
State/Province
Espirito Santo
ZIP/Postal Code
29101-850
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Vitória
State/Province
Espirito Santo
ZIP/Postal Code
29043-260
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Cuiabá
State/Province
Mato Grosso
ZIP/Postal Code
78048
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Belo Horizonte
State/Province
Minas Gerais
ZIP/Postal Code
30110-934
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Belo Horizonte
State/Province
Minas Gerais
ZIP/Postal Code
30150-221
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Belo Horizonte
State/Province
Minas Gerais
ZIP/Postal Code
30220-330
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Campina Grande Do Sul
State/Province
Parana
ZIP/Postal Code
83430-000
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Rio De Janeiro
State/Province
Rio Do Janeiro
ZIP/Postal Code
20241-180
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Natal
State/Province
Rio Grande Do Norte
ZIP/Postal Code
59025
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Passo Fundo
State/Province
Rio Grande Do Sul
ZIP/Postal Code
99010-260
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Porto Alegre
State/Province
Rio Grande Do Sul
ZIP/Postal Code
90020-090
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Porto Alegre
State/Province
Rio Grande Do Sul
ZIP/Postal Code
90035-004
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Porto Alegre
State/Province
Rio Grande Do Sul
ZIP/Postal Code
90035-903
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Porto Alegre
State/Province
Rio Grande Do Sul
ZIP/Postal Code
90610-000
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Porto Velho
State/Province
Rondonia
ZIP/Postal Code
78918-791
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Blumenau
State/Province
Santa Catarina
ZIP/Postal Code
89020-430
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Florianópolis
State/Province
Santa Catarina
ZIP/Postal Code
88015
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Itajaí
State/Province
Santa Catarina
ZIP/Postal Code
88301-220
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Itajaí
State/Province
Santa Catarina
ZIP/Postal Code
88301-260
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Joinville
State/Province
Santa Catarina
ZIP/Postal Code
89201
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Barretos
State/Province
Sao Paulo
ZIP/Postal Code
14784-400
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Bento Gonçalves
State/Province
Sao Paulo
ZIP/Postal Code
95700-084
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Botucatu
State/Province
Sao Paulo
ZIP/Postal Code
18618-970
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Campinas
State/Province
Sao Paulo
ZIP/Postal Code
13075
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Ijuí
State/Province
Sao Paulo
ZIP/Postal Code
98700-000
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Jaú
State/Province
Sao Paulo
ZIP/Postal Code
17210-120
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Osasco
State/Province
Sao Paulo
ZIP/Postal Code
06013-070
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Ribeirão Preto
State/Province
Sao Paulo
ZIP/Postal Code
14048-900
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Santa Catarina
State/Province
Sao Paulo
ZIP/Postal Code
88811-000
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
São José Do Rio Preto
State/Province
Sao Paulo
ZIP/Postal Code
15090-000
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
São Paulo
State/Province
Sao Paulo
ZIP/Postal Code
01509
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
São Paulo
State/Province
Sao Paulo
ZIP/Postal Code
04038-002
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
São Paulo
State/Province
Sao Paulo
ZIP/Postal Code
05403-000
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
São Paulo
State/Province
Sao Paulo
ZIP/Postal Code
08270-120
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Valinhos
State/Province
São Paulo
ZIP/Postal Code
13271-130
Country
Brazil
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T5A 4L8
Country
Canada
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Chicoutimi
State/Province
Quebec
ZIP/Postal Code
G7H 7Y8
Country
Canada
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Frankfurt am Main
State/Province
Hessen
ZIP/Postal Code
60596
Country
Germany
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Hamburg
ZIP/Postal Code
22143
Country
Germany
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Nellore
State/Province
Andhra Pradesh
ZIP/Postal Code
524001
Country
India
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Visakhapatnam
State/Province
Andhra Pradesh
ZIP/Postal Code
530002
Country
India
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Nellore
State/Province
Andhra Prasesh
ZIP/Postal Code
524001
Country
India
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Ahmedabad
State/Province
Gujarat
ZIP/Postal Code
380006
Country
India
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Sūrat
State/Province
Gujarat
ZIP/Postal Code
395004
Country
India
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Sūrat
State/Province
Gujarat
ZIP/Postal Code
395010
Country
India
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Faridabad
State/Province
Haryana
ZIP/Postal Code
121001
Country
India
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Bangalore
State/Province
Karnataka
ZIP/Postal Code
560060
Country
India
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Bangalore
State/Province
Karnataka
ZIP/Postal Code
560076
Country
India
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Bengaluru
State/Province
Karnataka
ZIP/Postal Code
560068
Country
India
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Nashik
State/Province
Maharashtra
ZIP/Postal Code
422005
Country
India
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Nashik
State/Province
Maharashtra
ZIP/Postal Code
422007
Country
India
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Pune
State/Province
Maharashtra
ZIP/Postal Code
411057
Country
India
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Jaipur
State/Province
Rajasthan
ZIP/Postal Code
302020
Country
India
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Chuo
State/Province
Chiba
ZIP/Postal Code
260-0852
Country
Japan
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Nishi-ku
State/Province
Fukuoka City
ZIP/Postal Code
819-0015
Country
Japan
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Fukuoka-Shi
State/Province
Fukuoka-Ken
ZIP/Postal Code
810-0033
Country
Japan
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Sapporo
State/Province
Hokkaido
ZIP/Postal Code
065-0033
Country
Japan
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Tsuchiura-shi
State/Province
Ibaraki
ZIP/Postal Code
300-0062
Country
Japan
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Tsukuba
State/Province
Ibaraki
ZIP/Postal Code
300
Country
Japan
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Kanazawa
State/Province
Ishikawa
ZIP/Postal Code
920-8650
Country
Japan
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Izumisano
State/Province
Osaka
ZIP/Postal Code
598-0048
Country
Japan
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Toda
State/Province
Saitama
ZIP/Postal Code
335-0035
Country
Japan
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Okayama
ZIP/Postal Code
700-0822
Country
Japan
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Toyama
ZIP/Postal Code
930-0152
Country
Japan
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Daugavpils
ZIP/Postal Code
LV-5410
Country
Latvia
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Riga
ZIP/Postal Code
LV-1010
Country
Latvia
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Cuauhtémoc
State/Province
Mexico City
ZIP/Postal Code
06700
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Monterrey
State/Province
Nuevo Leon
ZIP/Postal Code
64060
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Atea Study site
City
San Luis Potosí
State/Province
San Luis Potos
ZIP/Postal Code
78250
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Puebla
ZIP/Postal Code
72180
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Den Haag
ZIP/Postal Code
2565 KV
Country
Netherlands
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Utrecht
ZIP/Postal Code
3584
Country
Netherlands
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Zwijndrecht
ZIP/Postal Code
3333 GZ
Country
Netherlands
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Zwijndrecht
ZIP/Postal Code
3334 SB
Country
Netherlands
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Islamabad
ZIP/Postal Code
44000
Country
Pakistan
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Karachi
ZIP/Postal Code
74800
Country
Pakistan
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Karachi
ZIP/Postal Code
75600
Country
Pakistan
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Tacloban City
State/Province
Leyte
ZIP/Postal Code
6500
Country
Philippines
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Ermita
State/Province
Manila
Country
Philippines
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
San Fernando
State/Province
Pampanga
Country
Philippines
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Iloilo City
ZIP/Postal Code
5000
Country
Philippines
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Mandaluyong
ZIP/Postal Code
1552
Country
Philippines
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Bucuresti
ZIP/Postal Code
022328
Country
Romania
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Bucuresti
ZIP/Postal Code
030303
Country
Romania
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Bucuresti
ZIP/Postal Code
21105
Country
Romania
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Craiova
ZIP/Postal Code
200515
Country
Romania
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Oradea
ZIP/Postal Code
410176
Country
Romania
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Suceava
ZIP/Postal Code
720201
Country
Romania
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Timişoara
Country
Romania
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Pretoria
State/Province
Gauteng
ZIP/Postal Code
183
Country
South Africa
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Pretoria
State/Province
Gauteng
ZIP/Postal Code
84
Country
South Africa
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Randburg
State/Province
Gauteng
ZIP/Postal Code
2087
Country
South Africa
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Thabazimbi
State/Province
Limpopo
ZIP/Postal Code
380
Country
South Africa
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Kimberley
State/Province
Northern Cape
ZIP/Postal Code
8301
Country
South Africa
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Cape Town
State/Province
Western Cape
ZIP/Postal Code
7570
Country
South Africa
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Plettenberg Bay
State/Province
Western Cape
ZIP/Postal Code
6600
Country
South Africa
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Badalona
State/Province
Barcelona
ZIP/Postal Code
8916
Country
Spain
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Centelles
State/Province
Barcelona
ZIP/Postal Code
8540
Country
Spain
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Málaga
State/Province
Malaga
ZIP/Postal Code
29014
Country
Spain
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Marbella
State/Province
Málaga
ZIP/Postal Code
29603
Country
Spain
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Madrid
ZIP/Postal Code
28046
Country
Spain
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Solna
ZIP/Postal Code
17164
Country
Sweden
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Umeå
ZIP/Postal Code
90185
Country
Sweden
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Monastir
ZIP/Postal Code
5000
Country
Tunisia
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Sfax
ZIP/Postal Code
3029
Country
Tunisia
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Sousse
ZIP/Postal Code
4000
Country
Tunisia
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Sousse
ZIP/Postal Code
4054
Country
Tunisia
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Tunis
ZIP/Postal Code
1006
Country
Tunisia
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Tunis
ZIP/Postal Code
1029
Country
Tunisia
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Ankara
ZIP/Postal Code
6010
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Ankara
ZIP/Postal Code
6100
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Ankara
ZIP/Postal Code
6230
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Ankara
ZIP/Postal Code
6290
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Ankara
ZIP/Postal Code
6800
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Antalya
ZIP/Postal Code
7070
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Antalya
ZIP/Postal Code
7460
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Bursa
ZIP/Postal Code
16310
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Atea Study SIte
City
Denizli
ZIP/Postal Code
20160
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Istanbul
ZIP/Postal Code
34093
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Istanbul
ZIP/Postal Code
34098
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Istanbul
ZIP/Postal Code
34722
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Istanbul
ZIP/Postal Code
34785
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Istanbul
ZIP/Postal Code
34844
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Istanbul
ZIP/Postal Code
34899
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
İzmir
ZIP/Postal Code
35120
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
İzmir
ZIP/Postal Code
35620
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Atea Study SIte
City
Kayseri
ZIP/Postal Code
38080
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Samsun
ZIP/Postal Code
55270
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Exeter
State/Province
Devon
ZIP/Postal Code
EX2 5DW
Country
United Kingdom
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
Plymouth
State/Province
Devon
ZIP/Postal Code
PL6 8DH
Country
United Kingdom
Individual Site Status
Recruiting
Facility Name
Atea Study Site
City
London
State/Province
Greater London
ZIP/Postal Code
SE1 9RT
Country
United Kingdom
Individual Site Status
Recruiting

12. IPD Sharing Statement

Learn more about this trial

SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19

We'll reach out to this number within 24 hrs